These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26062137)

  • 1. A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus.
    Rajamuthiah R; Jayamani E; Conery AL; Fuchs BB; Kim W; Johnston T; Vilcinskas A; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(6):e0128576. PubMed ID: 26062137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
    Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.
    Yang N; Teng D; Mao R; Hao Y; Wang X; Wang Z; Wang X; Wang J
    Appl Microbiol Biotechnol; 2019 Jul; 103(13):5193-5213. PubMed ID: 31025073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of a
    Lindhauer NS; Bertrams W; Pöppel A; Herkt CE; Wesener A; Hoffmann K; Greene B; Van Der Linden M; Vilcinskas A; Seidel K; Schmeck B
    Virulence; 2019 Dec; 10(1):902-909. PubMed ID: 31657264
    [No Abstract]   [Full Text] [Related]  

  • 6. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.
    Abdelhady W; Bayer AS; Gonzales R; Li L; Xiong YQ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
    Mendes RE; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA; Nichol K; Zhanel GG
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
    Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L
    Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
    Marconescu P; Graviss EA; Musher DM
    Scand J Infect Dis; 2012 Aug; 44(8):620-2. PubMed ID: 22668202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
    Farrell DJ; Krause KM; Benton BM
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):275-9. PubMed ID: 21353951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tribolium castaneum defensins are primarily active against Gram-positive bacteria.
    Tonk M; Knorr E; Cabezas-Cruz A; Valdés JJ; Kollewe C; Vilcinskas A
    J Invertebr Pathol; 2015 Nov; 132():208-215. PubMed ID: 26522790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.
    Leuthner KD; Cheung CM; Rybak MJ
    J Antimicrob Chemother; 2006 Aug; 58(2):338-43. PubMed ID: 16787952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tribolium castaneum immune defense genes are differentially expressed in response to Bacillus thuringiensis toxins sharing common receptor molecules and exhibiting disparate toxicity.
    Contreras E; Benito-Jardón M; López-Galiano MJ; Real MD; Rausell C
    Dev Comp Immunol; 2015 Jun; 50(2):139-45. PubMed ID: 25684675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).
    Mendes RE; Sader HS; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):93-7. PubMed ID: 21851873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.